Skip to main content
Fig. 4 | BMC Bioinformatics

Fig. 4

From: Designing and development of multi-epitope chimeric vaccine against Helicobacter pylori by exploring its entire immunogenic epitopes: an immunoinformatic approach

Fig. 4

The final structure of the constructed vaccine and its validation. A The refined 3D model of the multi-epitope vaccine obtained from RaptorX shows the spatial arrangement of the epitopes within the vaccine structure. B ProSA structure validation displays a − 4.8 Z score, indicating the overall quality of the construction which is within an acceptable range. C Ramachandran plot analysis reveals that 82.4% of the amino acid residues in the vaccine structure are located in the favoured region, 16.6% of the residues fall within the allowed region, while only 1% are found in the disallowed region, indicating energetically favourable conformation, acceptable conformations, potentially unfavourable conformations, respectively

Back to article page